Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Very strong increase of sales during the third quarter

Q3 · Net sales reached SEK 19.5 (13.2) million. · Result after tax came in at SEK -7.7 (-9.6) million. · Earnings per share, basic and diluted, were SEK-0.05 (-0.11). · Cash and cash equivalents were SEK 30.7 (9.5) million. Significant events in Q3 · Enzymatica launched ColdZyme® Strawberry and broadened use to include soothe sore throat and alleviate common cold symptoms. · Sales surged on the Swedish market and ColdZyme continued to capture market share in terms of both value and volume. Sales on the Danish and Spanish markets also showed strong growth. ·

Interim report January - September 2019

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value rose to SEK 127 per share, compared with SEK 100 per share at the start of the year. This is an increase of 29.9 per cent, adjusted for dividends. By comparison, the Stockholm Stock Exchange's Total Return Index (SIXRX) increased by 23.0 per cent. The net asset value was SEK 133 per share at 4 November.(1) · The total return on the Latour share was 17.9 per cent during the period measured against the SIXRX, which rose 23.0 per cent. INDUSTRIAL OPERATIONS The third quarter · The industrial operations' order intake

Bioservo Technologies AB Interim report 1 January to 30 September 2019

Third quarter in figures · Net sales SEK 1.7 M (1.0) · EBITDA of SEK -4.6 M (-5.8) · EBIT of SEK -5.5 M (-6.7) · Earnings for the period was SEK -5.5 M (-6.7) · Earnings per share before and after dilution amounted to SEK -0.61 (-0.75) · At 30 September, cash and cash equivalents were SEK 9.4 M (32.1)   First nine months in figures · Net sales SEK 6.9 M (4.0) · EBITDA of SEK -13.8 M (-14.9) · EBIT of SEK -16.6 M (-17,2) · Earnings for the period was SEK -16.6 M (-17.2) · Earnings per share before and after dilution amounted to SEK -1.86 (-1.93) ·

Kallelse till extra bolagsstämma i TargetEveryOne AB (publ)

Aktieägarna i TargetEveryone AB (publ), org. nr. 556526-6748 (”Bolaget”), kallas härmed till extra bolagsstämma den 20 november 2019 klockan 11 på Kungsgatan 60, 1 tr. i Stockholm. Aktieägare som vill delta i stämman ska dels vara införda i den av Euroclear Sweden AB förda aktieboken den 14 november 2019, dels anmäla sitt deltagande till Bolaget senast den 14 november 2019, per post till adress TargetEveryOne AB, Kungsgatan 60, 1 tr, 112 22 Stockholm, eller per e-post (e-post_info@targeteveryone.com) info@targeteveryone.com. Vid anmälan anges namn, adress, telefonnummer, person- eller

Termination of project regarding ROR-gamma

In December 2011, Karo Pharma Aktiebolag (”Karo Pharma”) entered into a research collaboration and license agreement with Pfizer, with the purpose of discovering and developing substances that hamper the activity in the nuclear hormone receptor ROR-gamma, for treatment of autoimmune diseases. After completion of the initial research collaboration, Pfizer has conducted the development work in-house, in accordance with the terms of the agreement. Pfizer has informed Karo Pharma about its decision to terminate the specific development project, PF-06763809. As a result, Karo Pharma will not

Klaria acquires Uppsalagruppen and becomes the owner of the patent that protects Klaria’s technology platform

Klaria Pharma Holding AB (publ) (“Klaria”) today acquires Uppsalagruppen Medical AB (“Uppsalagruppen”) and the patent that protects Klaria’s drug delivery technology.  To date, Klaria has had a license from Uppsalagruppen to this patent for specific molecules.  With this acquisition, Klaria will now own the patent and have full freedom to develop novel drug candidates in the future.The transaction is structured as a share transfer agreement between the owners of Klaria and Uppsalagruppen, whereby all shares in Uppsalagruppen are acquired by Klaria. As consideration, Klaria has agreed to pay

Aspire Global’s Interim Report for the Third Quarter 2019 – Two Years of Sustained Growth

Third Quarter 2019 (JUL-SEP) · Revenues increased by 16.2% to €33.2 million (28.6) · B2B revenues increased by 37.9% to €21.0 million (15.2), constituting 63.0% of total revenues · EBITDA decreased by 16.0% to €5.2 million (6.2) · EBITDA for B2B increased by 15.0% to €4.3 million (3.7), constituting 82.0% of total EBITDA · EBITDA margin amounted to 15.7% (21.6%) · EBIT decreased to €4.3 million (5.7) · Earnings after tax decreased to €4.4 million (5.3) · Earnings per share after tax decreased to €0.09 (0.11) · First time depositors (FTDs) increased by 24.0% to

Starbreeze AB (publ) interim Q3 2019 report

Third quarter 2019 · Net sales amounted to SEK 21.1 million (33.9). PAYDAY accounted for SEK 17.5 million (20.9). · EBITDA amounted to SEK -10.9 million (-37.9). · Depreciation, amortization and impairments totalled SEK 94.9 million (49.5). · Costs related to the reconstruction amounted to SEK 4.5 million for the quarter.  · The loss before tax was SEK -68.4 million (-102.3). · Basic and diluted earnings per share were SEK -0.21 (-0.26). · The Stockholm District Court ruled that the reconstruction of Starbreeze was permitted to continue through 3 December 2019.

ÅF Pöyry acquires Cervino Consulting AB

The acquisition will make ÅF Pöyry a more complete supplier of engineering and design solutions in all areas of defenceCervino was founded in 2013 and offers consulting services to the defence, aviation and transport industries. The company works with operational and maintenance-related systems and offers project management, process innovation and support for transitioning to digital technology. ÅF Pöyry is today one of Sweden’s leading service providers to the Swedish defence sector. This acquisition will make ÅF Pöyry an even more complete supplier in all areas of defence and will

Ahlstrom-Munksjö and Metsä Fibre makes cross-audits in Germany

AHLSTROM-MUNKSJÖ, PRESS RELEASE, NOVEMBER 5, 2019 at 9:00 A.M. EETAhlstrom-Munksjö and Metsä Fibre continue collaboration in safety. A pilot program started with cross-audits in both companies’ production facilities in Finland in late 2018. After encouraging results the companies decided to expand auditing collaboration outside Finland. In the autumn 2019 Metsä Fibre safety professionals audited Ahlstrom-Munksjö plants in Dettingen and Unterkochen in Germany.Program tagline ‘Safety has no boundaries’ captures the essential idea of safety collaboration between the two companies. In

Neste’s new IMO2020-compliant low-sulphur marine fuel available in Germany

Neste Corporation, Press Release, 5 November 2019 at 9 a.m. (EET) Neste and the German BMT Bunker und Mineralöltransport GmbH have signed a partner agreement concerning distribution and sales of Neste MarineTM 0.5 . This new marine fuel, containing maximum 0.5% sulphur, has been available in Bremerhaven, Germany, since the beginning of November 2019.   BMT is a bunkering services company with a long experience in the sales of marine fuels. The company is well-known especially in the North Sea coast in

IAR Systems delivers development from device to cloud through integration with Amazon Web Services

Stockholm, Sweden—November 5, 2019— IAR Systems®, the future-proof supplier of software tools and services for embedded development, launches a new edition of IAR Embedded Workbench® for Arm® that provides integration with Amazon Web Services (AWS). “Embedded software development is extending into the cloud and developers need to be in control of application behavior through all execution stages to be able to optimize and debug their code in an efficient way,” says Anders Holmberg, Chief Strategy Officer, IAR Systems. “We provide developers with easy access to high-performance, pre-

IAR Systems delivers development from device to cloud through integration with Amazon Web Services

IAR Embedded Workbench for Arm now enables debugging all the way up to the cloudUppsala, Sweden—November 5, 2019—IAR Systems®, the future-proof supplier of software tools and services for embedded development, launches a new edition of IAR Embedded Workbench® for Arm® that provides integration with Amazon Web Services (AWS). IAR Embedded Workbench for Arm, AWS edition, provides developers with the possibility to log in to an AWS account from within the C/C++ development toolchain IDE. During debugging, they are able to access the TCP/IP interface, see the status of MQTT packages and

Boozt AB’s (publ) Nomination Committee appointed

The Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting and has the following composition: · Claus Wiinblad (representing ATP), Chairman of the Nomination Committee · Daniel Ahlstrand (representing Verdane Capital VII K/S) · Johannes Wingborg (representing Länsförsäkringar) · Henrik Theilbjørn, Chairman of the Board of Boozt AB (publ) The Chairman of the Board shall also summon the first meeting of the Nomination Committee. The Nomination Committee submits proposals to the AGM regarding the composition of the Board,

Interim report for the period January 1 – September 30, 2019

Net sales increased significantly during the quarter to SEK 35.3 million (8.9), attributable to deliveries within the customer segments geothermal and maritime. During the third quarter, gradual progress has been made on several fronts and we have worked methodically to close more new deals and at the same time deliver on the existing order backlog. Operating profit amounted to SEK -30.8 million (-23.3). The order backlog totaled SEK 781.6 million (815.6) at the end of the quarter.THIRD QUARTER 2019 JULY – SEPTEMBER · Net sales increased to SEK 35.3 million (8.9) · Order intake

Petteri Saarinen new CEO of LEDiL

Petteri Saarinen has been appointed as the new CEO of LEDiL, a leading company in the global LED secondary optics market. Petteri is a proven leader and has managed companies through both growth and turnaround, both as CEO and Chairman. Petteri will step into his new role in December. In conjunction with this, acting CEO Rami Huovinen will return to his role as a member of the Board of Directors of LEDiL.Petteri Saarinen has more than 20 years of operational and international experience within several different companies, and most recently comes from the CEO position in Trafotek. “I

BioArctic presents Nomination Committee and publishes financial calendar 2020

Stockholm, Sweden, November 5, 2019 – The Annual General Meeting of BioArctic AB on May 9, 2019, adopted instructions regarding the appointment of the Nomination Committee. Pursuant to these instructions the company shall have a Nomination Committee comprising one representative for each of the three largest shareholders in terms of votes based on the share register received from Euroclear Sweden AB on the last banking day in September 2019, as well as the Chairman of the Board (convener). The three largest shareholders are Demban AB, Ackelsta AB and Tredje AP-fonden, and together

Metsä Fibre and Ahlstrom-Munksjö makes cross-audits in Germany

Metsä Fibre press release 5.11.2019Metsä Fibre and Ahlstrom-Munksjö continue collaboration in safety. A pilot program started with cross-audits in both companies’ production facilities in Finland in late 2018. After encouraging results the companies decided to expand auditing collaboration outside Finland. In the autumn 2019 Metsä Fibre safety professionals audited Ahlstrom-Munksjö plants in Dettingen and Unterkochen in Germany. Program tagline ‘Safety has no boundaries’ captures the essential idea of safety collaboration between the two companies. In addition to cross-audits, the

Interim report third quarter 2019

Irisity AB (publ) delivers continued international expansion.The CEO comments on the third quarter: Sales amounted to MSEK 8.0 (9.4) and capitalized work amounted to MSEK 3.5 (4.5). Operating profit EBITDA amounted to SEK -0.6 M (2.6) and profit after tax to SEK -3.9 M (1.2). The equity / assets ratio strengthened to 71.6 percent (47.7). Gross margin was negatively impacted by costs associated with pilots and amounted to 62.6 percent (75.6). With a strong offering in the SaaS service IRIS, the company continues to take a position in the growing international market for high-precision

Interim report January-September 2019

Increased earnings and favourable growth in the companies during the third quarter· Net sales for Ratos business areas increased by 17%, 16% organic growth, and amounted to SEK 5,943m (5,071) · EBITA for Ratos business areas, excluding IFRS 16, amounted to SEK 302m (120) · Operating profit for the Group according to IFRS amounted to SEK 832m (184) · The sale of Ratos’s Lejonet 4 property has been completed. The capital gain amounted to SEK 487m and is included in operating profit for the Group · Cash and cash equivalents in the parent company amounted to SEK 1,565m At 10.00

Nomination committee appointed for Serneke Group AB’s Annual General Meeting 2020

The members of the nomination committee for Serneke Group AB’s Annual General Meeting in 2020 have now been appointed.The Serneke Group AB Annual General Meeting has resolved on the principles of how to appoint the nomination committee. According to these principles, the nomination committee shall be appointed following the chairman’s identification of the four largest shareholders, according to voting rights. These shareholders have the right to appoint a representative to the nomination committee. If one or more of the four largest shareholders refrain from their right to appoint a

Pandox completes a directed share issue of 16,350,000 class B shares, raising proceeds of approximately BSEK 3

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN, HONGKONG SWITZERLAND, SINGAPORE OR NEW ZEELAND OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Pandox AB (publ) (“Pandox” or the “Company”) has, based on the authorisation granted by the annual general meeting on 10 April 2019 and in accordance with what the Company indicated in a press release on 4 November 2019, resolved to carry out a directed share issue of 16,350,000 class B shares at a subscription price

Double-digit growth for all strategic brands in 9M 2019 and FY 2019 guidance raised

HIGHLIGHTS · Revenue reached DKK 12,615 million in the first nine months of 2019 representing a decline of 9% (9% in local currencies) compared to the same period last year. The decline was expected and a result of generic competition on Onfi® - excluding Onfi, revenue grew by 5% · Revenue of Abilify Maintena® increased 23% to DKK 1,457 million (21% in local currencies) · Revenue of Brintellix®/Trintellix® increased 31% to DKK 2,023 million (28% in local currencies) · Revenue of Northera® increased 25% to DKK 1,606 million (18% in local currency) · Revenue of

Sacro Cuore-Don Calabria Cancer Care Center treats its first patient with Elekta Unity MR-Linac

First care center in Italy offers patients the latest technology breakthrough in personalized cancer careNEGRAR-VERONA, Italy, November 5, 2019 – Elekta (EKTA-B.ST) today announced that the IRCCS Ospedale Sacro Cuore-Don Calabria Cancer Care Center has treated its first patient using Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation therapy. “The real-time images that Elekta Unity provides enables unprecedented precision in delivering therapeutic radiation, particularly to anatomies that can be clearly seen on

There are no items matching the current filter
There are no more items matching the current filter
Back to top